Bone Growth Stimulation Devices Market: Key Segments and Market Projections for 2030

 

Meticulous Research®—a renowned market intelligence and consulting firm—has unveiled its latest report, titled "Bone Growth Stimulators Market by Product (Stimulation Devices [External, Ultrasonic, Implantable], Bone Morphogenetic Proteins, Platelet-Rich Plasma), Application (Spinal Fusion, Fractures, Oral Surgeries), End User (Hospitals, ASCs) - Global Forecast to 2030."
Download Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=3530

According to this publication, the global bone growth stimulators market is projected to reach $1.94 billion by 2030, growing at a CAGR of 4.9% from 2023 to 2030. This growth is driven by the increasing demand for minimally invasive treatments, a surge in bone fractures and spinal injuries, an aging population contributing to orthopedic diseases and injuries, and a rising number of sports injuries. Additionally, expanding hospitals and surgical centers worldwide, growing applications of platelet-rich plasma (PRP), and opportunities in emerging markets are propelling this market forward.

Market Segmentation

The bone growth stimulators market is segmented into Product, Application, End User, and Geography:

1. By Product:

  • Bone Growth Stimulation Devices:
    • External Bone Growth Stimulators (Capacitive Coupling Devices, Combined Magnetic Field Devices, Pulsed Electromagnetic Field Devices)
    • Ultrasonic Bone Growth Stimulators
    • Implantable Bone Growth Stimulators
  • Bone Morphogenetic Proteins
  • Platelet-Rich Plasma (PRP)

In 2023, the Bone Growth Stimulation Devices segment is anticipated to hold the largest market share, primarily due to the rising prevalence of bone fractures, high demand for cost-effective and minimally invasive treatments, and the growing preference for non-invasive procedures.

2. By Application:

  • Spinal Fusion Surgeries
  • Union & Non-union Bone Fractures
  • Oral and Maxillofacial Surgeries
  • Other Applications

The Delayed Union & Non-union Bone Fractures segment is expected to grow at the highest CAGR during the forecast period, driven by an aging population prone to orthopedic conditions and challenges such as insufficient nutrition and blood supply that delay bone healing. According to the International Osteoporosis Foundation, osteoporosis causes 4.3 million fragility fractures annually in Europe, with healthcare costs amounting to $59.01 million (€56 billion). By 2034, the population aged 75 and older is projected to rise significantly, further escalating osteoporotic fractures.

3. By End User:

  • Hospitals & Specialized Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Other End Users

In 2023, the Hospitals & Specialized Clinics segment is expected to dominate the market. This dominance is attributed to the wide availability of hospitals in urban and rural areas, increasing patient visits for orthopedic care, and a growing pool of skilled medical professionals.

4. By Geography:

In 2023, North America is expected to hold the largest share of the global market, driven by high healthcare expenditures, an aging population, rapid technological advancements, and high adoption rates of innovative healthcare products.

Key Players

Leading companies in the bone growth stimulators market include:

  • Orthofix Medical Inc. (U.S.)
  • Zimmer Biomet Holdings, Inc. (U.S.)
  • Medtronic, plc (Ireland)
  • Stryker Corporation (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • DJO, LLC (U.S.)
  • Bioventus LLC (U.S.)
  • OssaTechnics BV (Germany)
  • Arthrex GmbH (U.S.)
  • Smith & Nephew plc (U.K.)
  • ITO Co., Ltd. (Japan)

These companies are actively investing in product innovation, expanding their global presence, and enhancing their portfolios to address the rising demand for bone growth stimulators worldwide.

Quick Buy: https://www.meticulousresearch.com/Checkout/73200843

About Us

Meticulous Research® is a trusted partner for businesses worldwide, providing actionable market intelligence to drive revenue growth and strategic transformation. Supporting Fortune 500 companies and emerging enterprises, we deliver insights that uncover forward-looking opportunities and enable competitive advantage through syndicated reports, custom research, and direct analyst engagement.

Each year, we conduct over 300 syndicated studies and manage more than 60 consulting engagements across eight industries and 20+ geographic markets. Our focus is on addressing the complex challenges faced by global business leaders, helping them make informed decisions that drive sustainable growth and operational excellence.

Contact Us

Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Email: sales@meticulousresearch.com
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Visit Our Website: https://www.meticulousresearch.com/

Follow Us for Updates:

Comments

Popular posts from this blog

E-bikes Market to be Worth $88.3 Billion by 2030—Exclusive Report by Meticulous Research®”

U.S. Ambulatory EHR Market to be Worth $3.57 Billion by 2030

Wi-Fi 6 Market Worth $105.4 Billion by 2028